Health Highlights: From Sudan Hunger Crisis to Drug Approvals and Public Safety

The latest health news covers a variety of topics: almost 20 million people in Sudan face severe hunger, the FDA approves BeOne's cancer drug, and no link is found between autism and antidepressant use during pregnancy. Meanwhile, the hantavirus risk in the U.S. remains low, and new drug developments are underway.

A global hunger monitor reports that 19.5 million Sudanese, over 40% of the population, are experiencing acute hunger due to a devastating three-year war.

The U.S. FDA has approved Beqalzi, a new drug for treating aggressive blood cancer mantle cell lymphoma, developed by BeOne Medicines.

Recent research involving 25 million pregnancies finds no increased risk of autism with antidepressant use during pregnancy, contradicting claims by public figures.